Suppr超能文献

早期心脏植入式电子设备感染的抗生素预防和治疗。

Antibiotic Prophylaxis and Treatment in Early Cardiac Implantable Electronic Devices Infection.

机构信息

Department of Cardiology, Queen Alia Heart Institute, Royal Medical Services, Amman, Jordan.

出版信息

Med Arch. 2021 Feb;75(1):56-60. doi: 10.5455/medarh.2021.75.56-60.

Abstract

BACKGROUND

Cardiac implantable electronic devices - PM, ICD, and CRTs- are well-proven life-sustaining and the ultimate destination for many heart conditions. Based on scientific evidence, there is a worldwide incremental increase in CIED implantations numbers.

OBJECTIVE

Early infection of cardiac implantable electronic devices (CIED)- pacemaker (PM), implantable cardioverter-defibrillator (ICD), and cardiac resynchronization therapy (CRT)- is a growing health challenge. We examined the effectiveness of antibiotic prophylaxis and treatment of early infection of CIED in a single center.

METHODS

This is a retrospective, single-center observational study. Data were collected from patients' records from July 2017-July, 2019. All Patients received intravenous ceftriaxone 2gm before incision, Gentamicin 120mg pocket irrigation, and oral Amoxicillin/Clavulanate for 5 days post-implantation.

RESULTS

A 639 consecutive CIED implantations - PM (n=474, mean age, 64yr, female=49%), ICD (n=106, mean age 56yr, female=17%) and CRT (n=59, mean age, 54yr, female=20%)- were performed over 3years. The incidence of early infection was 1.9% (12 cases), female=41%. PM=5/474, ICD=5/106, and CRT=2/59. Three out of the 12 patients had total device explant due to pocket abscess; one PM had a generator changed; one ICD who had a pneumothorax, and the third one had reimplantation after ICD lead perforation. Nine cases were managed conservatively using saline dressing and oral Amoxicillin/Clavulanate, 3/9 patients developed a hematoma, 4/9 patients developed purulent suture line infection. None of them had infection recurrence on three months follow up.

CONCLUSION

Early infection of CIED is a rare complication with multiple predisposing factors. Our protocol is reassurance and prompt initiation of management protocol to prevent and treat this issue's sequences.

摘要

背景

心脏植入式电子设备 - 起搏器 (PM)、植入式心律转复除颤器 (ICD) 和心脏再同步治疗 (CRT) - 已被证明可维持生命,是许多心脏疾病的最终治疗选择。基于科学证据,全球心脏植入式电子设备 (CIED) 的植入数量呈递增趋势。

目的

心脏植入式电子设备 (CIED) - 起搏器 (PM)、植入式心律转复除颤器 (ICD) 和心脏再同步治疗 (CRT) - 的早期感染是一个日益严峻的健康挑战。我们在单一中心检验了抗生素预防和治疗 CIED 早期感染的效果。

方法

这是一项回顾性、单中心观察性研究。数据来自 2017 年 7 月至 2019 年 7 月间患者的病历记录。所有患者在切开前均接受静脉注射头孢曲松 2 克、庆大霉素 120 毫克囊袋冲洗,以及术后 5 天口服阿莫西林/克拉维酸钾。

结果

在 3 年时间里,我们共进行了 639 例连续的 CIED 植入手术 - PM(n=474,平均年龄 64 岁,女性占 49%)、ICD(n=106,平均年龄 56 岁,女性占 17%)和 CRT(n=59,平均年龄 54 岁,女性占 20%)。早期感染的发生率为 1.9%(12 例),女性占 41%。PM 为 5/474,ICD 为 5/106,CRT 为 2/59。12 例早期感染患者中有 3 例因囊袋脓肿而完全取出设备;1 例 PM 更换了发生器;1 例 ICD 出现气胸,第 3 例因 ICD 导线穿孔而重新植入。9 例患者采用盐水敷料和口服阿莫西林/克拉维酸钾保守治疗,其中 3/9 例出现血肿,4/9 例出现脓性缝线感染。在三个月的随访中,均未发现感染复发。

结论

CIED 的早期感染是一种罕见的并发症,有多种诱发因素。我们的方案是提供保证,并及时启动管理方案,以预防和处理这一问题。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e11/8116075/06a7a3111638/medarch-75-56-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验